Posted Date : August 16,2021
Product (RFP/RFQ/RFI/Solicitation/Tender/Bid Etc.) ID : PHAR-0771
Government authority located in Jackson, Mississippi; USA based organization looking for expert vendor for pharmacy preferred drug services.
[A] Budget: Looking for Proposal
[B] Scope of Service:
(1) Vendor needs to provide pharmacy preferred drug services to develop and manage the universal preferred drug list, administer the supplemental drug rebate program, manage the rate setting of covered outpatient drugs, and perform programmatic review and assessment of core components of the pharmacy program as assigned by division of Medicaid to the government authority located in Jackson, MS.
- All relevant evidence and citations regarding drugs and products must be in this report, including but not limited to, the comparative efficacy, side effects, dosing, prescribing trends and indications
- The review schedule shall also include ‘off cycle’ reviews of drugs and products new to the market which are not included in the annual therapeutic class review
(2) All question must be submitted no later than September 1, 2021.
[C] Eligibility:
- Onshore (USA ONLY);
[D] Work Performance:
Performance of the work will be Offsite.
Budget :
Deadline to Submit Proposals: September 27,2021
Cost to Download This RFP/RFQ/RFI/Solicitation/Tender/Bid Document : 5 US$
![]()
Product (RFP/RFQ/RFI/Solicitation/Tender/Bid Etc.) ID : PHAR-0771
Government authority located in Jackson, Mississippi; USA based organization looking for expert vendor for pharmacy preferred drug services.
[A] Budget: Looking for Proposal
[B] Scope of Service:
(1) Vendor needs to provide pharmacy preferred drug services to develop and manage the universal preferred drug list, administer the supplemental drug rebate program, manage the rate setting of covered outpatient drugs, and perform programmatic review and assessment of core components of the pharmacy program as assigned by division of Medicaid to the government authority located in Jackson, MS.
- All relevant evidence and citations regarding drugs and products must be in this report, including but not limited to, the comparative efficacy, side effects, dosing, prescribing trends and indications
- The review schedule shall also include ‘off cycle’ reviews of drugs and products new to the market which are not included in the annual therapeutic class review
(2) All question must be submitted no later than September 1, 2021.
[C] Eligibility:
- Onshore (USA ONLY);
[D] Work Performance:
Performance of the work will be Offsite.
Budget :
Deadline to Submit Proposals: September 27,2021
Cost to Download This RFP/RFQ/RFI/Solicitation/Tender/Bid Document : 5 US$